| Literature DB >> 26351578 |
Juan Torrado1, Ignacio Farro1, Yanina Zócalo1, Federico Farro1, Claudio Sosa2, Santiago Scasso2, Justo Alonso2, Daniel Bia1.
Abstract
Introduction. An altered endothelial function (EF) could be associated with preeclampsia (PE). However, more specific and complementary analyses are required to confirm this topic. Flow-mediated dilation (FMD), low-flow-mediated constriction (L-FMC), and hyperemic-related changes in carotid-radial pulse wave velocity (PWVcr) offer complementary information about "recruitability" of EF. Objectives. To evaluate, in healthy and hypertensive pregnant women (with and without PE), central arterial parameters in conjunction with "basal and recruitable" EF. Methods. Nonhypertensive (HP) and hypertensive pregnant women (gestational hypertension, GH; preeclampsia, PE) were included. Aortic blood pressure (BP), wave reflection parameters (AIx@75), aortic pulse wave velocity (PWVcf) and PWVcr, and brachial and common carotid stiffness and intima-media thickness were measured. Brachial FMD and L-FMC and hyperemic-related change in PWVcr were measured. Results. Aortic BP and AIx@75 were elevated in PE. PE showed stiffer elastic but not muscular arteries. After cuff deflation, PWVcr decreased in HP, while GH showed a blunted PWVcr response and PE showed a tendency to increase. Maximal FMD and L-FMC were observed in HP followed by GH; PE did not reach significant arterial constriction. Conclusion. Aortic BP and wave reflections as well as elastic arteries stiffness are increased in PE. PE showed both "resting and recruitable" endothelial dysfunctions.Entities:
Year: 2015 PMID: 26351578 PMCID: PMC4550743 DOI: 10.1155/2015/720683
Source DB: PubMed Journal: Int J Hypertens Impact factor: 2.420
Figure 1Schema of the instrumental approach employed to assess noninvasive arterial structure and function in basal and post-VRT conditions. Employed techniques are as follows: carotid-to-femoral and carotid-to-radial PWV (applanation tonometry and mechanography), PWA (applanation tonometry), arterial diameters and CIMT (B-Mode ultrasound), and blood flow velocities (Doppler ultrasound). PWA: pulse wave analysis; PWV: pulse wave velocity; AP: augmentation pressure; Δt 1, Δt 2: time delay between R wave from ECG and carotid foot wave and femoral/radial foot wave, respectively; Δt 3: time delay between carotid foot wave and femoral/radial foot wave; cSBP/pSBP: central/peripheral systolic blood pressure; cDBP/pDBP: central/peripheral diastolic blood pressure; DD: diastolic diameter; SD: systolic diameter; CIMT: carotid intima-media thickness; Z: acoustic impedance; C-F and C-R Δx: carotid-to-femoral and carotid-to-radial distance, respectively.
Figure 2Representative diagram of the study protocol applied to evaluate changes in arterial parameters. PWVcr: carotid-to-radial pulse wave velocity; BP: blood pressure; HR: heart rate.
Demographic and laboratory samples characteristics of the study populations according to pregnancy status.
| Healthy pregnant (HP) | Gestational hypertension (GH) | Preeclampsia (PE) |
| |
|---|---|---|---|---|
| MV ± SD | MV ± SD | MV ± SD | ||
|
| 10 | 8 | 8 | |
| Age (years) | 29.4 ± 6.2 | 30.9 ± 6.7 | 33.6 ± 5.9 | 0.373 |
| Gestational age (weeks) | 34.6 ± 3.7 | 34.9 ± 2.9 | 36.3 ± 2.2 | 0.502 |
| Number of gestations ( | 1.8 ± 2.1 | 4.5 ± 3.8 | 3.5 ± 4.5 | 0.286 |
| Weight (kg) | 67.1 ± 7.3 | 76.5 ± 10.9 | 97.0 ± 12.6a,b | <0.001 |
| Height (cm) | 157.6 ± 6.8 | 159.6 ± 5.3 | 160.3 ± 8.6 | 0.703 |
| BMI (kg/m2) | 27.1 ± 3.6 | 30.2 ± 5.4 | 38.1 ± 6.6a,b | 0.001 |
| Creatinine (mg/dL) | 0.7 ± 0.1 | 0.6 ± 0.1 | 0.6 ± 0.1 | 0.664 |
| Uric acid (mg/dL) | 3.2 ± 1.1 | 4.1 ± 1.4 | 6.7 ± 2.5a,b | 0.001 |
| 24-hour proteinuria (g) | 0.0 ± 0.1 | 0.2 ± 0.1a | 0.5 ± 0.1a,b | <0.001 |
| SGOT (UI/L) | 12.2 ± 3.2 | 15.7 ± 5.9 | 14.5 ± 2.5 | 0.722 |
| SGPT (UI/L) | 11.5 ± 5.2 | 13.7 ± 6.0 | 11.8 ± 4.1 | 0.587 |
| LDH (UI/L) | 320.5 ± 59.7 | 347.8 ± 49.8 | 386.9 ± 93.3 | 0.846 |
| Hematocrit (%) | 31.7 ± 3.7 | 34.2 ± 2.9 | 33.7 ± 2.0 | 0.681 |
| Platelets ( | 213.0 ± 78.0 | 195.4 ± 60.0 | 202.6 ± 45.6 | 0.862 |
Values are expressed as mean value (MV) ± standard deviation (SD). Post hoc test with multiple comparisons: a and b indicate P < 0.05 with respect to HP and GH, respectively. All comparisons were determined using ANOVA + Bonferroni test. HP: healthy pregnancies; GH: gestational hypertension; PE: preeclamptic pregnancies; BMI: body mass index; SGOT: serum glutamic-oxaloacetic transaminase; SGPT: serum glutamic-pyruvic transaminase; LDH: lactate dehydrogenase. Between groups.
Baseline cardiovascular characteristics of the study populations according to pregnancy status.
| Healthy pregnant (HP) | Gestational hypertension (GH) | Preeclampsia (PE) |
| |
|---|---|---|---|---|
| MV ± SD | MV ± SD | MV ± SD | ||
| Heart rate (bpm) | 81.8 ± 15.9 | 84.8 ± 9.7 | 85.3 ± 14.0 | 0.844 |
| Peripheral SBP (mmHg) | 111.8 ± 8.2 | 139.4 ± 6.0a | 145.5 ± 7.5a | <0.001 |
| Peripheral DBP (mmHg) | 63.5 ± 9.5 | 78.9 ± 11.9a | 84.6 ± 8.8a | <0.001 |
| MBP (mmHg) | 79.6 ± 5.8 | 99.0 ± 6.3a | 105.9 ± 7.3a | <0.001 |
| Peripheral PP (mmHg) | 50.7 ± 18.6 | 58.6 ± 11.4 | 58.0 ± 12.7 | 0.571 |
| Central SBP (mmHg) | 96.7 ± 6.7 | 118.9 ± 3.9a | 130.3 ± 5.8a,b | <0.001 |
| Central DBP (mmHg) | 63.5 ± 9.5 | 80.4 ± 11.2a | 85.6 ± 10.0a | <0.001 |
| Central PP (mmHg) | 33.2 ± 11.4 | 35.5 ± 7.1 | 42.8 ± 10.8 | 0.041 |
| Amplification ratio | 1.5 ± 0.2 | 1.7 ± 0.2 | 1.4 ± 0.2b | <0.001 |
| AIx@75 (%) | 12.2 ± 12.4 | 11.8 ± 7.6 | 24.3 ± 5.7a,b | 0.018 |
| Carotid-to-femoral PWV (m/s) | 5.6 ± 0.8 | 7.1 ± 0.8a | 8.2 ± 1.2a | <0.001 |
|
| ||||
| Carotid-to-radial PWV (m/s) | 7.0 ± 1.6 | 7.1 ± 0.9 | 6.0 ± 1.1 | 0.159 |
| Brachial SR (s−1) | 117.9 ± 43.1 | 102.8 ± 26.7 | 93.4 ± 43.5 | 0.417 |
| Brachial SD (mm) | 3.8 ± 0.3 | 3.9 ± 0.4 | 4.3 ± 0.5 | 0.149 |
| Brachial DD (mm) | 3.7 ± 0.3 | 3.7 ± 0.4 | 4.1 ± 0.4 | 0.210 |
| Brachial | 1010 ± 464 | 1188 ± 832 | 1183 ± 350 | 0.754 |
| Brachial | 11.4 ± 5.0 | 11.1 ± 8.3 | 11.3 ± 3.4 | 0.953 |
|
| ||||
| Right CCA SD (mm) | 7.1 ± 0.6 | 7.1 ± 0.6 | 7.1 ± 0.5 | 0.988 |
| Right CCA DD (mm) | 6.5 ± 0.6 | 6.5 ± 0.6 | 6.7 ± 0.5 | 0.749 |
| Right | 355 ± 102 | 434 ± 161 | 709 ± 185a,b | <0.001 |
| Right CCA | 4.56 ± 1.47 | 5.24 ± 3.07 | 6.95 ± 1.58 | 0.073 |
| Right CIMT (mm) | 0.47 ± 0.10 | 0.55 ± 0.08 | 0.66 ± 0.21a | 0.036 |
|
| ||||
| Left CCA SD (mm) | 7.1 ± 0.4 | 7.2 ± 0.3 | 7.1 ± 0.7 | 0.932 |
| Left CCA DD (mm) | 6.5 ± 0.4 | 6.6 ± 0.2 | 6.7 ± 0.6 | 0.637 |
| Left CCA | 376 ± 153 | 471 ± 182 | 714 ± 256a | 0.005 |
| Left CCA | 4.8 ± 2.0 | 5.6 ± 3.1 | 7.0 ± 2.4 | 0.205 |
| Left CIMT (mm) | 0.51 ± 0.09 | 0.55 ± 0.08 | 0.59 ± 0.10 | 0.162 |
Values are expressed as mean value (MV) ± standard deviation (SD). Post hoc test with multiple comparisons: a and b indicate P < 0.05 with respect to HP and GH, respectively. All comparisons were determined using ANOVA + Bonferroni test. HP: healthy pregnancies; GH: gestational hypertension; PE: preeclamptic pregnancies; SBP: systolic blood pressure; DBP: diastolic blood pressure; MBP: mean blood pressure; PP: pulse pressure; AIx@75: augmentation index adjusted to a heart rate of 75 bpm; PWV: pulse wave velocity; SR: shear rate; SD and DD: systolic and diastolic diameter, respectively; E : Peterson's elastic modulus; β: stiffness index; CCA: common carotid artery; CIMT: carotid intima-media thickness. Between groups.
VRT-related changes in vascular parameters of the study groups according to pregnancy status.
| Healthy pregnant (HP) | Gestational hypertension (GH) | Preeclampsia (PE) |
| |
|---|---|---|---|---|
| MV ± SD | MV ± SD | MV ± SD | ||
| FMD (%) | 9.4 ± 3.0 | 3.6 ± 3.3a | 2.2 ± 2.9a | <0.001 |
| L-FMC (%) | −7.8 ± 3.7 | −4.5 ± 2.1 | −0.7 ± 3.5a | <0.001 |
| ΔPWVcr (%) | −13.9 ± 9.4 | −0.9 ± 6.9a | 7.0 ± 8.5a | <0.001 |
| Peak shear rate (s−1) | 231.7 ± 72.6 | 237.6 ± 67.5 | 219.5 ± 59.5 | 0.86 |
| ΔShear rate (%) | 113.8 ± 87.4 | 131.2 ± 53.7 | 168.6 ± 97.1 | 0.39 |
Values are expressed as mean value (MV) ± standard deviation (SD). Post hoc test with multiple comparisons: a indicate P < 0.05 with respect to HP and GH, respectively. All comparisons were determined using ANOVA + Bonferroni test. HP: healthy pregnancies; GH: gestational hypertension; PE: preeclamptic pregnancies; FMD: flow-mediated dilation; L-FMC: low-flow-mediated constriction; PWVcr: carotid-to-radial pulse wave velocity. Between groups.
Figure 3Correlation analysis between EF parameters. FMD: flow-mediated dilation; L-FMC: low-flow-mediated constriction; ΔPWVcr%: percentage of change in carotid-to-radial pulse wave velocity.